These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 18791331

  • 1. Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.
    Hermann EJ, Hattingen E, Krauss JK, Marquardt G, Pilatus U, Franz K, Setzer M, Gasser T, Tews DS, Zanella FE, Seifert V, Lanfermann H.
    Stereotact Funct Neurosurg; 2008; 86(5):300-7. PubMed ID: 18791331
    [Abstract] [Full Text] [Related]

  • 2. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
    Muragaki Y, Chernov M, Maruyama T, Ochiai T, Taira T, Kubo O, Nakamura R, Iseki H, Hori T, Takakura K.
    Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C, Hattingen E, Pilatus U, Franz K, Schänzer A, Lanfermann H, Seifert V, Gasser T.
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Stadlbauer A, Buchfelder M, Doelken MT, Hammen T, Ganslandt O.
    Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
    [Abstract] [Full Text] [Related]

  • 5. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O.
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [Abstract] [Full Text] [Related]

  • 6. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N, Morales H, Modrego PJ, Pina MA.
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsy.
    Setzer M, Herminghaus S, Marquardt G, Tews DS, Pilatus U, Seifert V, Zanella F, Lanfermann H.
    Acta Neurochir (Wien); 2007 Jun; 149(4):379-86. PubMed ID: 17380247
    [Abstract] [Full Text] [Related]

  • 8. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
    Ng WH, Lim T.
    J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
    [Abstract] [Full Text] [Related]

  • 9. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
    Catalaa I, Henry R, Dillon WP, Graves EE, McKnight TR, Lu Y, Vigneron DB, Nelson SJ.
    NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
    [Abstract] [Full Text] [Related]

  • 10. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [Abstract] [Full Text] [Related]

  • 11. [Significance of stereotactic biopsy for the management of WHO grade II supratentorial glioma].
    Muacevic A, Kreth FW.
    Nervenarzt; 2003 Apr; 74(4):350-4. PubMed ID: 12707704
    [Abstract] [Full Text] [Related]

  • 12. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):126-37. PubMed ID: 15093908
    [Abstract] [Full Text] [Related]

  • 13. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S, Tsugu H, Komatsu F, Abe H, Onishi H, Ohmura T, Iwaasa M, Sakamoto S, Fukushima T.
    Anticancer Res; 2007 May 01; 27(6A):3757-63. PubMed ID: 17970039
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW.
    Radiology; 2002 Mar 01; 222(3):715-21. PubMed ID: 11867790
    [Abstract] [Full Text] [Related]

  • 16. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N, Dávila J, Medrano J, Olmos S.
    Eur J Radiol; 2008 Sep 01; 67(3):427-33. PubMed ID: 18442889
    [Abstract] [Full Text] [Related]

  • 17. Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
    Batra A, Tripathi RP, Singh AK.
    Australas Radiol; 2004 Sep 01; 48(3):324-32. PubMed ID: 15344981
    [Abstract] [Full Text] [Related]

  • 18. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
    Zhou GF, Wang XY, Gong CG, Liu F, Wang RW.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 01; 28(8):1342-4. PubMed ID: 18753055
    [Abstract] [Full Text] [Related]

  • 19. [Image guided stereotactic biopsy for brain tumors: experience of 71 cases].
    Matsumoto K, Tomita S, Higashi H, Nakagawa M, Adachi H, Tada E, Maeda Y, Ohmoto T.
    No Shinkei Geka; 1995 Oct 01; 23(10):897-903. PubMed ID: 7477699
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.